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IL-1 is now recognized as a family of polypeptides that mediate a wide variety
of biological responses to injury and infection (1). Two biochemically distinct
forms of IL-1 are produced by monocytes and macrophages; these two forms
have thus far been found in every species studied, and have now also been
characterized by cDNA cloning experiments, using mRNA from both human
and murine monocytes as the starting material (2-4). The cDNAs have been
expressed in Escherichia coli and the rIL-1 proteins have been purified to
homogeneity (2-4). IL-1/3 (pI 7.0) is the predominant species ofIL-1 in activated
human monocytes, and mRNA coding for this molecule composes ?90% of total
monocyte IL-1 mRNA (3, 4). IL-la (pl 5.0) is correspondingly less abundant in
human monocytes(4). The secreted forms ofboth IL-1fl andIL-la gene products
appear to mediate similar if not identical biological activities on a wide variety
of target tissues (5).
Recently (1, 6), it has become evident that secretion of polypeptides with IL-
1-like activity is not limited to cells of the monocyte/macrophage lineage.
Notably, keratinocytes have been shown to produce an epidermal cell-derived
thymocyte activating factor (ETAF) that is functionally and biochemically similar
to IL-1 (7). However, a recent report (8) has raised the possibility that ETAF
and IL-1 maydiffer by certain criteria. It has also become clear that the epidermis
represents an enormous reservoir of IL-1 activity ; 1 gm of human stratum
corneum contains 106 units of IL-1 activity (9). In our hands, this is comparable
to the amount of IL-1 found in 10 liters of conditioned medium from LPS-
stimulated human monocytes(our unpublished observations). When IL-1 activity
in the viable layers ofepidermis is also taken into account, it would appear that
epidermis contains quantities of IL-1 activity that are comparable to those in the
entire reticuloendothelial system. The present study was designed to compare
Address correspondence to Dr. Thomas S. Kupper, Dept. of Dermatology, Yale University School
of Medicine, 333 Cedar Street, New Haven, CT 06510.
J. Exp. MED. CThe Rockefeller University Press - 0022-1007/86/12/2095/06 $1 .00
￿
2095
Volume 164 December 1986 2095-21002096
￿
KUPPER ET AL.
￿
BRIEF DEFINITIVE REPORT
monocyte-derived IL-1 and keratinocyte-derived ETAF at the molecular level.
Evidence is presented that strongly suggests that IL-1 and ETAF are identical.
In addition, keratinocytes appear to produce predominantly IL-la, in contrast
to LPS-stimulated human peripheral blood monocytes that produce predomi-
nantly IL-1#.
Materials and Methods
Keratinocytes.
￿
A431, a cell line derived from an epidermal carcinoma, was obtained
from Lloyd King (Vanderbilt University, Nashville, TN) and was maintained in DMEM
containing 10% FCS. Human foreskin keratinocytes (HFK) were grown by the method of
Rheinwald and Green (10). For all studies, confluent cultures of HFK were maintained in
the absence of the 10-s M hydrocortisone normally included in the standard culture
medium (10).
Antibodies.
￿
A rabbit antiserum to human monocyte IL-1 primarily active against IL-
1,0 (11) was provided by Charles Dinarello (Tufts University School of Medicine, Boston,
MA). An IgG fraction of rabbit antiserum to human monocyte IL-1 that neutralizes both
IL-la and IL-1fl activity (R. Newton, personal communication) was provided by Robert
Newton (DuPont Co., Glenolden, PA).
IL-1.
￿
HFK- and A431-conditioned media were obtained after incubation of fresh
tissue culture medium with confluent cultures of the appropriate cell line for 48 h.
Affinity-purified human monocyte IL-1,B (11) was provided by Charles Dinarello.
IL-1 Assay. The assay to detect IL-1 activity uses the T cell clone D10 and the
clonotype-specific mAb 3D3 or Con A, and has been described in detail (12). 6 h before
harvest, [sH]thymidine (1 uCi per well; 1 Ci = 37 GBq) was added. Cultures were harvested
on an automated sample harvester (Cambridge Technology, Inc., Cambridge, MA) and
radioactivity was measured with a scintillation spectrometer (Beckman Instruments, Inc.
Fullerton, CA).
S1 Nuclease Protection Assay.
￿
An S1 nuclease protection assay requires the use of an
end-labeled probe complementary to the mRNA to be detected (13). To achieve this,
cDNA clones for human IL-la (14) and IL-1,8 (3) were first modified by deleting one of
the homopolymeric tails used in the original cloning. S 1 probes, free of homopolymeric
tails, were then generated for IL-la by labeling a 960-bp Hind III-Pst I fragment at the
Hind III site in the strand complementary to the mRNA, and for IL-1,B by labeling an
855-bp Hind III-Taq I fragment at the Hind III site in the strand complementary to the
mRNA. The specific activities of these probes were determined for each preparation and
were usually on the order of 1-2 x 104 dpm/fmol. 2-5 fmol of end-labeled a and fl
probes were hybridized separately to 5-50 ug of total RNA sample in 80% deionized
formamide, 0.4 M NaCl, 1 mM EDTA, 40 mM Pipes (pH 6 .8) at 52°C overnight. After
this incubation, each sample was digested for 60 min at 37° C with 100 units of S 1 nuclease
(15). The products were subsequently analyzed on a 5% sequencing gel. The sizes of the
protected fragments in this assay are 210 nucleotides for IL-la (corresponding to the
coding region for amino acids 64-134 of the complete IL-la precursor) and 525
nucleotides for IL-1,8 (corresponding to the coding region for amino acids 133-269 of
the complete IL-1,B precursor plus 116 nucleotides of the 3' untranslated region).
To determine relative mRNA levels, films were scanned at 550 nm and areas under
the peaks were cut out and weighed. The values obtained were corrected for the fact that
the specific activity of the IL-la probe was 1 .9 times that of the IL-1fl probe.
Results and Discussion
Affinity-purified human monocyte IL-1,8 induces the proliferation of D10 cells
in the presence of 3D3 antibody, shown in Fig. IA. This activity can be
substantially blocked by an antibody specific for human IL-1,6 (11). Similarly, a
second polyclonal antibody which neutralizes both IL-la and # with equalO
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FIGURE 1 . (A) Monocyte IL-1,B is neutralized by two different antibodies to IL-1. Serial
dilutions of 25 1A/mlof affinity-purifiedmonocyte IL-10(11) were added to 2 X 10" D10 cells
in the presence of a 1:1,000 dilution of 3D3 hybridoma supernatant. In addition, 1%
nonimmune rabbit serum (filled circle), 1% immune rabbit serum active against IL-10(filled
triangle), or 125 jAg/ml of immune rabbit serum (IgG fraction)that neutralizes both IL-laand
#(Newton, R., personal communication) (open circle) were added. Both antibodies neutralize
monocyte IL-I activity. (B) Keratinocyte ETAF IL-1 activity is neutralized by an antibody that
neutralizes IL-la andIL-1fl, butnotby an antibody that neutralizes only IL-1,8. Serial dilution
of a 25% conditioned medium from HFKS were added to 2 X 10' cells in the presence of
1:1,000 dilution of 3D3 hybridoma supernatant. Antibody additions are identical to those in
Fig. 1A (see legend).
efficency (Newton, R., personal communication) also blocks this activity. These
antibodies had no effect on the IL-2-inducedproliferation ofD10cells, indicating
both specificity and lack of nonspecific cytotoxicity (data not shown). Fig. 1 B
shows that conditioned media from HFK also have significant IL-1 activity, as
measured by proliferation of D10 cells in the presence of 3D3 antibody. In
contrast, this activity cannot be neutralized by theantibody specific for monocyte
IL-la. The antibody that blocks both IL-la and IL-la activity, however, neu-
tralizes this IL-1 activity completely. These data suggest that the IL-1 activity
present in human keratinocyte-conditioned medium more closely resembles IL-
la than IL-118.
HFK and A431 cells represent homogeneous populations of normal and
malignant keratinocytes, respectively . A comparison of RNA extracted from
these cell lines with RNA from LPS-stimulated human peripheral blood leuko-
cytes was made by an S1 nuclease protection assay, using cDNA probes for
human monocyte IL-la and ,B. Such an assay permits the inference ofidentity if
protection from S1 digestion occurs, since the S1 enzyme digests single-stranded
but not double-stranded RNA or DNA. While complete homology between
cDNA and mRNA results in a perfectly matched double strand resistant to S1
digestion, even single base mismatches in the cDNA/mRNA hybrids wouldresult
in the degradation ofthe labeled probe by S1 nuclease.
Fig. 2, A and B shows an S1 nuclease protection assay using both the a and 182098
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FIGURE 2.
￿
S1 nuclease protection assay of total RNAs from HFKS, A431, LPS-stimulated
peripheral blood leukocytes, and pig intestine using 12P-labeled cDNA probes for human
monocytic IL-la (A)and IL-1,B (B). The protectedfragments are indicated by arrowheads . See
text for further explanations. Samples are : lane 1, uninduced HFKS (20,ug) ; lane 2, A431 (16
jug); lane 3, LPS-stimulated peripheral blood leukocytes (8 /Ig, positive control) ; lane 4, pig
intestine (30 ug, negative control); lane 5, no RNA. M, marker (pBR322-Hinf I digest) ; N,
sizes in nucleotides . The films were scanned at 550 nm and the relative ratios of IL-la to IL-
10 RNAs were determined from the areas under the peaks (determined by weighing),
correcting for the fact that the specific activity of the aprobe was about twofold higher than
for the 1S probe . See Results .
probes, respectively . A comparison of the first lanes in Fig . 2, A andB indicates
that normal unstimulated HFK contain mRNAs that protect IL-la and IL-10
cDNA probes from S1 digestion . The reason that the IL-1a probe gives rise to
two protected fragments even for the homologous RNA from LPS-stimulated
peripheral blood leukocytes (positive control) is due to the presence of an S1-
sensitive site rich in A-T basepairs located -125 nucleotides away from the
labeled end of the probe . This observation lends further support to the notion
that protection from S1 digestion in such an assay is a stringent criterion for
completed nucleic acid homology . Two to three times more mRNA for IL-la
than ,8 is present in HFKS ; in contrast, LPS-stimulated monocytes (lane 3) express
10-20-fold more IL-1,B mRNA than IL-1amRNA . A431 cells appear to contain
substantially less IL-1 mRNA per total RNA, and contain approximately five
times more IL-lei than a mRNA (lane 2) . Porcine intestine RNA does not
hybridize with either probe (lane 4), and no spontaneous S1-mediated digestion
of labeled probe is seen when RNA is not included in the reaction (lane 5) .
The data presented above indicate that, by several criteria, ETAF and IL-1
are identical. As shown by S1 nuclease protection analysis, mRNAs from both a
malignant human keratinocyte line (A431) and HFK protect cDNA probes for
monocytic IL-1a and IL-1# from S1 digestion . Given the stringency of the S1KUPPER ET AL.
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assay, it can be concluded that keratinocytes, like monocytes, contain IL-1a and
IL-1,B mRNAs. This conclusion is further supported by the finding that kerati-
nocyte ETAF activity is completely blocked in vitro by antibodies to monocytic
IL-1. Keratinocytes contain more IL-Ia mRNAthan IL-10mRNA inthe absence
of apparent stimulation. This relative abundance of IL-la mRNA is also seen
after UVB irradiation in vitro, which significantly enhances IL-1 gene expres-
sion.' IL-1 protein secreted by keratinocytes also consists predominantly of IL-
la, since an antibody that blocks IL-1,B does not neutralize this activity. In
contrast, monocyte IL-1/3 mRNA and protein is at least 10 times more abundant
than IL-la (3, 4).
Unstimulated human monocytes contain very small quantities of IL-la and ,B
mRNA (reference 4 and our unpublished observations); however, after stimula-
tion with LPS, significant levels of these mRNAs can be detected. While we
cannot exclude the possibility that picograms of LPS are responsible for the
apparent constitutive production ofIL-1 mRNA and protein in cultures ofHFK,
we cannot detect LPS in our cultures by the limulus assay, and the addition of
polymixin B (16) has no effect on resting keratinocyte production ofIL-1 activity
(not shown). Therefore, we consider this possibility unlikely.
Both IL-la and IL-I,l appear to act through the same receptor to induce the
same biological effects (5). Keratinocyte IL-1 (produces more a than ,B) and
monocyte IL-1 (produces more Q than a), however, may play different biological
roles. Skin is the principal barrier between the external environment and the
body. The release of preformed IL-1 from injured skin may thus provide the
initial signal to the immune system that disruption or penetration of the integu-
ment has occurred. The IL-1-rich environment of the wound may provide an
adjuvant effect on immune responses to foreign antigens encountered in this
setting. In the absence of injury, the normal desquamation of terminally differ-
entiated, nonviable keratinocytes provides a satisfactory mode for the excretion
of this predominantly cell-associated factor. This mechanism may enable the
keratinocyte to produce IL-1 constitutively without causing systemic effects.
Summary
Keratinocytes produce an IL-1 like factor termed epidermal cell-derived
thymocyte-activating factor (ETAF). In this study, we show that ETAF and IL-
1 are identical by the following criteria: (a) Both normal and malignant human
keratinocytes contain mRNAs identical to monocytic IL-la and IL-10 mRNA,
as determined byan S1 nuclease protection assay; and(b) IL-1 activity in medium
conditioned by these cells can be neutralized by antibodies specific for human
IL-1 . The IL-la and IL-1,B mRNAs can be identified in cultured human kerati-
nocytes in the absence of identifiable stimulation; this basal level of mRNA can
be further induced to accumulate with certain defined stimuli. Cultured normal
human keratinocytes (HFKs) contain 2-4 times more IL-la than IL-10 mRNA;
in contrast, human peripheral blood monocytes contain 10-20 times more IL-
10 than IL-la mRNA. The IL-1 activity released by these HFK can be neutral-
ized by an antibody that neutralizes both a and ,B IL-l, but not by an antibody
' Kupper, T. S., U. Gubler, A. Chua, J. S. McGuire, P. Flood. Interleukin I gene expression in
human keratinocytes is augmented by ultraviolet (UVB) irradiation. Submitted forpublication.2100
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that neutralizes only IL-1(3. While human monocytes produce a large excess of
IL-1,8 after appropriate stimulation, these data suggest that IL-la is a major (and
may be the predominant) form of IL-1 produced by human keratinocytes.
Receivedfor publication 18July 1986 and in revisedform 8 September 1986.
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